BETA

44 Amendments of Rosa ESTARÀS FERRAGUT related to 2016/2096(INI)

Amendment 2 #
Motion for a resolution
Citation 1
– having regard to the Treaty on the Functioning of the European Union, and in particular Articles 19 and 168(7) thereof,
2016/10/18
Committee: FEMM
Amendment 13 #
Motion for a resolution
Citation 7 a (new)
– having regard to the 2008 European Pact for Mental Health and Well-Being,
2016/10/18
Committee: FEMM
Amendment 16 #
Motion for a resolution
Citation 7 b (new)
– having regard to the Commission Joint Action on Mental Health and Well- Being (2013-2016).
2016/10/18
Committee: FEMM
Amendment 20 #
Motion for a resolution
Recital A
A. whereas the right to physical and mental health is a fundamental human right;
2016/10/18
Committee: FEMM
Amendment 33 #
Motion for a resolution
Recital C a (new)
Ca. whereas mental health must be seen and addressed holistically, by taking account of social, economic, and environmental factors, requiring a psychosocial all-of-society approach to attaining the highest possible level of mental well-being for all citizens;
2016/10/18
Committee: FEMM
Amendment 34 #
Motion for a resolution
Recital C b (new)
Cb. whereas physical and mental health are interlinked, and are both central to general wellbeing; whereas it is recognised that poor mental health can lead to chronic physical conditions, and that those with chronic physical conditions are more likely to develop mental health conditions; whereas despite the known links between the two, physical health research is often prioritised over mental health;
2016/10/18
Committee: FEMM
Amendment 35 #
Motion for a resolution
Recital C c (new)
Cc. whereas women and girls’ mental health is adversely affected by a variety of factors, including prevalent gender stereotypes and discrimination, objectification, gender-based violence and harassment, workplace environment, work-life balance, socioeconomic conditions, the absence or poor quality of mental health education, and limited access to mental healthcare;
2016/10/18
Committee: FEMM
Amendment 43 #
Motion for a resolution
Recital E
E. whereas the fact that many women lack of access to sexual and reproductive rights, including safe and legal abortion services, endangers the life and health of women and girls, increases maternal mortality and morbidity, and leads to the denial of life- saving care and to an increased number of clandestine abortionshealth services has a major impact on their well-being;
2016/10/18
Committee: FEMM
Amendment 58 #
Motion for a resolution
Recital G
G. whereas female migrants, and female refugees in particular, may additionally face specific problems related to reproductive health such as complications with pregnancy and childbirth, as well as a risk of exposure to (sexual) violence and abuse;
2016/10/18
Committee: FEMM
Amendment 73 #
Motion for a resolution
Recital L
L. whereas in terms of mental health problems, which are different from psychiatric disorders, vary across gendersthere are differences between men and women: women have higher rates of depression and anxiety (referred to as internalising disorders) and men have higher rates of substance abuse and antisocial disorders (referred to as externalising disorders);
2016/10/18
Committee: FEMM
Amendment 95 #
Motion for a resolution
Recital M
M. whereas, because of a variety of factors, primarily concerning different gender roles and gender inequalitiesces and inequalities between men and women, depression is approximately twice as prevalent among women as it is among men;
2016/10/18
Committee: FEMM
Amendment 96 #
Motion for a resolution
Recital M a (new)
Ma. whereas there is not enough attention to mental health and wellbeing in the education system across Member States, or at the workplace, given that mental health is often highly stigmatised, or a taboo subject; whereas education on mental health fights the stigma on the subject, it must also address gender specific vulnerabilities, gender stereotypes and discrimination facing women and girls;
2016/10/18
Committee: FEMM
Amendment 98 #
Motion for a resolution
Recital M b (new)
Mb. whereas the psychosocial all-of- society approach to mental health requires policy coherence for wellbeing, coordinating healthcare, education, employment, economic and social policies in order to attain overall higher levels of mental wellbeing;
2016/10/18
Committee: FEMM
Amendment 109 #
Motion for a resolution
Recital O
O. whereas male violence against women and its impacts on women’s health constitute a fundamental barrier to the achievement of gender equality and women’s full enjoyment of their human rights;
2016/10/18
Committee: FEMM
Amendment 111 #
Motion for a resolution
Recital P a (new)
Pa. whereas men and boys experience gendered mental health conditions and an increased likelihood of substance abuse, alcoholism, violent crime and suicide; whereas men and boys face gender stereotypes surrounding masculinity which may encourage repression of emotions or resort to anger, and these have an impact on men’s mental health, as well as the phenomenon of gender based violence;
2016/10/18
Committee: FEMM
Amendment 120 #
Motion for a resolution
Recital Q
Q. whereas, for several reasons, female subjects have historically been excluded from toxicology or biomedical research, and whereas large gender gaps in research limit how much we know about the difference between women’s health and men’s; whereas, as a result, biomedical research has tended to reflect predominantly a male perspective, assimilating women to men (except for specific specialisations);
2016/10/18
Committee: FEMM
Amendment 121 #
Motion for a resolution
Recital Q a (new)
Qa. whereas the exclusion and underrepresentation of women as subjects, or gender and sex as factors in biomedical research and clinical trials puts women’s lives and health at risk;
2016/10/18
Committee: FEMM
Amendment 123 #
Motion for a resolution
Recital Q b (new)
Qb. whereas the Regulation (EU) No 536/2014 on clinical trials of medicinal products for human use introduced requirements for taking account of gender in trials, but the implementation of the regulation must be evaluated; whereas the regulation does not specify any considerations on women other than for pregnant and breastfeeding women;
2016/10/18
Committee: FEMM
Amendment 124 #
Motion for a resolution
Recital R a (new)
Ra. whereas the impacts of such drugs and medication as contraception devices, antidepressants and tranquilizers have on women’s physical and mental health are still poorly understood, and require further research to eliminate harmful side-effects and improve care delivery;
2016/10/18
Committee: FEMM
Amendment 126 #
Motion for a resolution
Recital R a (new)
Ra. whereas there are about 58 000 suicide cases a year in the EU and a quarter of those who commit suicide are women, and whereas suicide continues to be a major cause of death;
2016/10/18
Committee: FEMM
Amendment 127 #
Motion for a resolution
Recital R b (new)
Rb. whereas mental disorders are one of the main causes of incapacity, adversely affecting as they do health, education, the economy, the labour market, and the EU’s welfare systems;
2016/10/18
Committee: FEMM
Amendment 133 #
Motion for a resolution
Paragraph 1 – point a
(a) to take stock of the specific health needs of women and to ensure the integration of a gender perspective in all aspects oftheir health policies, programmes and research from their development and design to impact assessment and budgeting;
2016/10/18
Committee: FEMM
Amendment 141 #
Motion for a resolution
Paragraph 1 – point b
(b) to recognise male violence against women as a public health issue, whatever form it takes;
2016/10/18
Committee: FEMM
Amendment 145 #
Motion for a resolution
Paragraph 1 – point c
(c) to support civil society and women’s organisations that promote women’s rights, including women’s sexual and reproductive health and rights, and to work to ensure that women have a voice in European and national health policy issues;
2016/10/18
Committee: FEMM
Amendment 155 #
Motion for a resolution
Paragraph 1 a (new)
1a. Emphasises that the Commission and Member States must recognise gender-based violence as a public health issue, whatever form it takes, which directly impacts on women’s mental health and wellbeing; notes that more research is needed on the mental health impact of gender-based violence, including verbal and psychological violence, harassment and intimidation;
2016/10/18
Committee: FEMM
Amendment 162 #
Motion for a resolution
Paragraph 1 e (new)
1e. Underlines that social and employment policy, particularly policies on work-life balance, must take women’s mental health and wellbeing into account;
2016/10/18
Committee: FEMM
Amendment 173 #
Motion for a resolution
Paragraph 2 a (new)
2a. Calls on the Commission, Member States and EIGE to increase the collection of regular, gender disaggregated data on mental health, in particular on the prevalence of depression, this data being disaggregated at least by sex, gender, age group and socioeconomic status;
2016/10/18
Committee: FEMM
Amendment 183 #
Motion for a resolution
Paragraph 2 e (new)
2e. Urges the Commission and Member States to include the mental health and wellbeing challenges faced by men and boys due to gender stereotypes leading to increased likelihood of substance abuse and suicides than women; Underlines that policies on men’s mental health must also take into account the perspective of age and lifespan, socio- economic condition, social exclusion, and geographic factors;
2016/10/18
Committee: FEMM
Amendment 190 #
Motion for a resolution
Paragraph 3
3. Considers that sexual and reproductive rights include universal open access to legal and safe abortion, reliable, safe and affordable contraception, and sexual education and information on sexual and reproductive health, free choice and consent; calls on the Commission and the Member States to promote sexual and reproductive health and rights, adequate gender-sensitive information and reliable, safe and affordable contraception, and to provide access to legal and safe abortion within and beyond the European Unionalls on the Commission and the Member States to promote health, adequate information for men and women, and the exchange of best practice in the field of mental health and clinical research;
2016/10/18
Committee: FEMM
Amendment 199 #
Motion for a resolution
Paragraph 4
4. Considers it regrettable that sexual and reproductive rights are severely limited and/or subject to certain conditions in several EU Member States;deleted
2016/10/18
Committee: FEMM
Amendment 207 #
Motion for a resolution
Paragraph 5
5. Is of the opinion that the increasing number of medical professionals who refuse to perform abortions in Member States represents another threat to the health and rights of women;deleted
2016/10/18
Committee: FEMM
Amendment 225 #
Motion for a resolution
Paragraph 9
9. Calls on the Member States to ensure full, in accordance with their national law, access to high-quality primary health care for all migrant women, irrespective of their legal status, and, in the longer term, to adequately prepare their national health systems;
2016/10/18
Committee: FEMM
Amendment 242 #
Motion for a resolution
Paragraph 11
11. Is disappointed by the fact that the annual budgets for programmes designed to prevent male violence against women in all Member States isare much less than the actual cost of such violence, be it in economic, social or moral in nature;
2016/10/18
Committee: FEMM
Amendment 253 #
Motion for a resolution
Paragraph 13
13. Calls on the Member States to take measures to ensure access to healthcare services – including women’s shelters – to all women, independent of their legal status, disability status, sexual orientation, race or ethnic origin, age or religion;
2016/10/18
Committee: FEMM
Amendment 265 #
Motion for a resolution
Paragraph 14
14. Considers that the lack of comparable, comprehensive, reliable and regularly updated gender-disaggregated data constitutes a source of discrimination for women’s health; calls for the EU institutions and the Member States therefore to promote and make mandatory the collection of comparable gender- disaggregated data at EU and national level;
2016/10/18
Committee: FEMM
Amendment 268 #
Motion for a resolution
Paragraph 15 a (new)
15a. Believes that the action taken at EU level on mental health and well-being should involve leading figures in the political, health, education, and social spheres, together with the social partners and civil society organisations; considers it essential that mental health should cease to be a taboo subject in certain social environments;
2016/10/18
Committee: FEMM
Amendment 270 #
Motion for a resolution
Paragraph 15 a (new)
15a. Welcomes the moves by the Commission for the EU to ratify the Istanbul Convention, and regrets that many Member States have not done so yet; urges the Council to ensure EU accession to the Istanbul Convention as soon as possible;
2016/10/18
Committee: FEMM
Amendment 272 #
Motion for a resolution
Paragraph 15 b (new)
15b. Calls for measures to be taken to reduce the risk factors involved in suicide, such as alcohol abuse, drugs, social exclusion, depression, and stress; also calls for systems to be set up to provide support following suicide attempts;
2016/10/18
Committee: FEMM
Amendment 276 #
Motion for a resolution
Paragraph 16
16. Underlines the fact that clinical trials of pharmaceutical products on both men and women are necessary and that these should be inclusive, non- discriminatory and performed under conditions of equality, inclusion and non- marginalisationzation, and reasonably reflective of the population that would use the products; suggests that clinical trials also take account of specific vulnerable population groups such as paediatric and geriatric patients, persons, and ethnic minorities; is of the opinion that gender- disaggregated data should also be collected after commercialisation of the products, in order to record the different side-effects, as well as research and data on the implementation of the relevant EU legislation by Member States;
2016/10/18
Committee: FEMM
Amendment 279 #
Motion for a resolution
Paragraph 16 a (new)
16a. Expresses deep concern that the failure to improve women’s representation in clinical trials and biomedical research puts women’s health and lives at risk;
2016/10/18
Committee: FEMM
Amendment 293 #
Motion for a resolution
Paragraph 20
20. Urges the European Medicines Agency (EMEA) to draw up separate guidelines for women as a special population in clinical trialsconsider the representation of women in clinical trials and determine whether there are particular circumstances requiring greater attention;
2016/10/18
Committee: FEMM
Amendment 296 #
Motion for a resolution
Paragraph 21 a (new)
21a. Urges Member States, the EMEA, and relevant stakeholder to ensure that sex and gender factors are introduced at the earliest stages of research and development of medication, before the stage of clinical trials; Emphasises the need for improved sharing of best practice among research institutions and healthcare providers across Europe on the subject;
2016/10/18
Committee: FEMM
Amendment 297 #
Motion for a resolution
Paragraph 21 b (new)
21b. Underlines that urgent action is required to correct gender gaps in clinical trials in areas of health where such gaps are particularly harmful, such as in medication for Alzheimer’s, cancer, treatment of strokes, anti-depressants, and cardio-vascular diseases;
2016/10/18
Committee: FEMM
Amendment 298 #
Motion for a resolution
Paragraph 21 c (new)
21c. Emphasises that concerted action must be taken by researchers and all relevant stakeholders to eliminate harmful side effects of medication that specifically affect women, such as in anti- depressants and contraception and other drugs, in order to improve women’s health, and the quality of healthcare;
2016/10/18
Committee: FEMM